Prenuvo
Latest round
- Series B
Last raised
- Jun 2024
Total raised
- $126M
Investors
- 3
About Prenuvo
Based in California, US, Prenuvo Inc. operates as a healthcare chain offering MRI screening of the whole body for cancer detection. The company offers radiation-free whole-body imaging for early detection of cancer and other diseases, through its MRI machine which only takes 20 mins to 60 minutes to complete instead of traditional methods that take 3 to 4 hours. The company’s scan through its software and AI technology covers 26 regions or organs of the body and can diagnose over 500 health conditions including most solid tumors at Stage 1. Prenuvo has grown in revenue by 240% year-over-year as of October 2022 and it generates its revenue by offering its scan services under different prices including USD 999 for a torso scan, USD 1799 for a head and torso scan, and USD 2499 for a full body scan.
Who invested in Prenuvo
3 investors across 2 rounds
See all investors in Prenuvo
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Prenuvo
Who invested in Prenuvo?
Prenuvo has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prenuvo raised?
Prenuvo has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Prenuvo last raise money?
Prenuvo's most recent round on record is a Series B, in Jun 2024.
What does Prenuvo do?
Based in California, US, Prenuvo Inc.
Where is Prenuvo headquartered?
Prenuvo is headquartered in Redwood City, US.
Which VCs invest in companies like Prenuvo?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Prenuvo's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like Prenuvo? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.